Stevanato Group, a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it has secured €200 million in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM. These fundings are intended to support the Company’s ongoing capital expenditure projects in Cisterna di Latina (Italy) and Fishers (Indiana, U.S.).
The financing agreements bolster Stevanato Group’s capacity expansion efforts and the scaling of commercial production to support customers’ growing biologics programs. CDP has committed €50 million to enhance the production of pre-filled syringes and set up future capacity for ready-to-use (RTU) cartridges at Stevanato Group’s Italian plant in Cisterna di Latina.
Additionally, BNL BNP Paribas has provided €100 million, and Banco BPM has contributed €50 million, both aimed at scaling pre-filled syringe production at the company’s facilities in North America (Indiana) and Italy, as well as completing the ongoing construction for device manufacturing in Fishers.
BNL BNP Paribas and Cassa Depositi e Prestiti have renewed their support for Stevanato Group to achieve long-term organic growth objectives in its key end-markets.
KEY QUOTES:
“These agreements are an important element to Stevanato Group’s financial strategy, allowing us to capitalize on robust customer demand and support the Company’s long-term growth objectives. We are committed to supporting our customers’ biopharmaceutical programs with our unique value proposition of offering integrated solutions across the pharmaceutical value chain, helping to enable our customers to meet and exceed their program objectives.”
Marco Dal Lago, Chief Financial Officer of Stevanato Group
“Our support for Stevanato Group reflects our commitment to partnering with companies that invest in innovation, sustainability and global expansion. Stevanato Group is a leading example of excellence in its sector, and our goal is to make our domestic and international platforms available to contribute to the growing ambitions of the Company in the coming years.”
Gianluca Mariani, Head of Industrial Manufacturing, Large Corporate Banking at BNL BNP Paribas
“We are proud to once again support the growth plans of Stevanato Group, a leading Italian company active in the pharmaceutical sector, which is strategic for the Country. We firmly believe in the value of companies that invest in research, quality, and sustainable development, and that make a tangible contribution to the growth of the national economy. We remain committed to standing alongside these businesses, providing effective financial instruments to support their growth and consolidation plans both in Italy and internationally.”
Marco Roberto Pessione, Head of Corporate Coverage at CDP
“We are proud to support a company like Stevanato Group, a symbol of Italian industrial excellence worldwide, in its solid and innovation-driven growth journey. This financing reflects our commitment to backing projects that create value locally while strengthening the international competitiveness of Italian enterprises.”
Enrico Lemmo, Head of Corporate Banking North-East at Banco BPM
